Skip to content
Screener

Vestis VSTS Reimbursements of tenant improvement allowances

Reimbursements of tenant improvement allowances at other companies

Piper Sandler logo
Piper SandlerPIPR
$23.47M+143%
Piper Sandler logo
Piper SandlerPIPR
$23.47M+143%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$5.8M
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$5.8M
Evercore logo
EvercoreEVR
$16.93M-6.0%
Evercore logo
EvercoreEVR
$16.93M-6.0%

Other financials

Income statement

See full
Revenue$659.4M-0.9%
Gross profit$173.7M-0.9%
Operating income$26.8M+412%
Net income$2.6M+109%
EPS (diluted)$0.02+110%

Balance sheet

See full
Cash & equivalents$50.3M+74.8%
Total debt$1.4B-1.8%
Total equity$867.2M-1.0%
Total assets$2.9B-1.2%

Cash flow

See full
Operating cash flow$58.3M+775%
CapEx$12.7M-6.1%
Free cash flow$45.6M+765%

Valuation

See full
Market cap$1.88B+221%
Enterprise value$3.2B+62.8%
P/S0.7×+0.5×

Profitability

See full
Gross margin26.1%-1.9pp
Operating margin3.2%-0.1pp
Net margin-0.6%
FCF margin3.6%-6.6pp

Returns & leverage

See full
Return on equity-2%
Debt / equity1.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Vestis in its filing.

Tagged under the XBRL concept vsts:ProceedsFromTenantAllowance.

The source filing: Vestis’s 10-K, filed December 2, 2025.

Filed
Dec 2, 2025
Fiscal year
FY2025
Accession
0001628280-25-054597

(1) For fiscal 2025, excludes cash paid for variable and short-term lease costs of $13.0 million and $7.2 million, respectively, that are not included within the measurement of lease liabilities. For fiscal 2024, excludes cash paid for variable and short-term lease costs of $10.4 million and $8.7 million, respectively, that are not included within the measurement of lease liabilities. For fiscal 2023, excludes cash paid for variable and short-term lease costs of $9.9 million and $8.2 million, respectively, that are not included within the measurement of lease liabilities. Additionally, for fiscal 2025 and 2024, includes $0.1 million and $4.5 million, respectively, of cash received for reimbursements of tenant improvement allowances.

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Vestis's reimbursements of tenant improvement allowances?
Vestis (VSTS) reported reimbursements of tenant improvement allowances of $25K in Q3 2025.
How has Vestis's reimbursements of tenant improvement allowances changed year-over-year?
Vestis's reimbursements of tenant improvement allowances decreased by 97.8% year-over-year, from $1.13M to $25K.
What does reimbursements of tenant improvement allowances mean?
Represents cash received from landlords as incentives or reimbursements for leasehold improvements made to rented properties. This metric serves as a contra-expenditure item that offsets the capital cost of facility upgrades. It provides insight into the company's ability to negotiate favorable lease terms and manage capital expenditure requirements.

Ask your AI about Vestis's reimbursements of tenant improvement allowances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude